Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000094

Chief Scientific Officer acquired 76,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mahaney Paige · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-28 Grant or award : show line 1 in the form +76,800 76,800 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-28 Grant or award : show line 2 in the form Stock Option (Right to Buy) +345,600 345,600 D
Loading xslF345X05/wk-form4_1730233884.xml…